
|
Slideshows
|
|
Development on San Bruno Mountain could help, as well as hurt, environmental goals for the 1,300-foot peak. Swiss pharmaceutical maker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc., seizing the opportunity offered by the weak U.S. dollar to grab a bigger share of earnings from such Genentech drugs as the blockbuster cancer treatment Avastin.
Commuters ready to launch
Plans are afloat to construct two new ferry launches on San Francisco’s waterfront, part of a plan to spin a web of ferry routes throughout the Bay. A planned ferry system between Redwood City and San Francisco that would reportedly shuttle 1,420 passengers between the two cities in fewer than 50 minutes has made it over its first bureaucratic hurdle.
Cracks slow Caltrain commute
Caltrain riders were hit with a one-two punch at the height of the morning commute Wednesday after unrelated mechanical problems in both directions caused delays of up to an hour. San Carlos will become the sixth city on the Peninsula to install a red-light camera at a major intersection as three other cities in San Mateo County eye the popular devices.
Genentech 2Q profit rises, but misses forecast
Biotechnology company Genentech Inc. says sales of its cancer treatments, led by blockbuster drugs Avastin and Rituxan, drove nearly 5 percent growth in second-quarter profit, but the results didn't meet Wall Street forecasts.
Voters’ wallets open wider
Local taxpayers must foot a bill for more than $15 million for recent school improvements they did not approve, including $3 million in payments to bond issuers, according to a civil grand jury investigation. Bay Area drivers, already battling record transportation costs, may soon have to pay more to park at San Francisco International Airport. |
|
|
Sports
Business |
Real Estate Family Movies and Books Venues, Sports and Music Concerts, Artists and Tickets Be Inspired - Quotes and Stories |